NASDAQ:BFRGW Bullfrog AI (BFRGW) Stock Price, News & Analysis → Your Money is Not Safe (From American Alternative) (Ad) Free BFRGW Stock Alerts $0.43 -0.02 (-4.44%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.43▼$0.4950-Day Range$0.43▼$1.0752-Week Range$0.30▼$1.74Volume2,320 shsAverage Volume22,607 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Bullfrog AI alerts: Email Address Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Bullfrog AI Stock (NASDAQ:BFRGW)BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.Read More BFRGW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BFRGW Stock News HeadlinesApril 11, 2024 | stockhouse.comBullFrog AI's CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & ExpoApril 9, 2024 | finance.yahoo.comBullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & ExpoApril 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.April 4, 2024 | finance.yahoo.comCEO and 10% Owner Vininder Singh Sells 50,000 Shares of Bullfrog AI Holdings Inc (BFRG)March 15, 2024 | msn.comHuge ‘aggressive’ frog — that ‘will jump at an elephant’ — discovered as new speciesFebruary 5, 2024 | finance.yahoo.comBullFrog AI Announces Closing of $5.7 Million Public OfferingFebruary 1, 2024 | finance.yahoo.comBullfrog AI Announces Pricing of $5.7 Million Public OfferingJanuary 26, 2024 | finance.yahoo.comBullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah WalaApril 25, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.January 20, 2024 | ca.finance.yahoo.comBullfrog AI Holdings, Inc. (BFRGW)January 17, 2024 | msn.comBullfrog AI stock rallies 32% on early brain research resultsJanuary 5, 2024 | benzinga.comA Major Leap Forward For Drug Development? How BullFrog's AI Platform Is Driving Research ForwardDecember 30, 2023 | finanznachrichten.deBullFrog AI Holdings, Inc.: BullFrog AI Issues Letter to ShareholdersDecember 6, 2023 | finance.yahoo.comBullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling ObesitySee More Headlines Receive BFRGW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bullfrog AI and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolNASDAQ:BFRGW CUSIPN/A CIK1829247 Webwww.bullfrogai.com Phone240-658-6710FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$65,000.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Vininder Singh (Age 53)Founder, Chairman & CEO Comp: $179kMr. Dane R. Saglio (Age 65)Chief Financial Officer Comp: $30kMr. J. T. KoffenbergerChief Information OfficerMr. William HirschmanChief Commercial OfficerDr. David P. Recker FACP (Age 65)FACR, M.D., Chief Medical Officer Key CompetitorsAclarionNASDAQ:ACONWBrightSpring Health ServicesNASDAQ:BTSGUCareCloudNASDAQ:CCLDPCareCloudNASDAQ:CCLDOCareMaxNASDAQ:CMAXWView All Competitors BFRGW Stock Analysis - Frequently Asked Questions How have BFRGW shares performed in 2024? Bullfrog AI's stock was trading at $0.9550 at the beginning of the year. Since then, BFRGW stock has decreased by 55.0% and is now trading at $0.43. View the best growth stocks for 2024 here. Are investors shorting Bullfrog AI? Bullfrog AI saw a drop in short interest in March. As of March 31st, there was short interest totaling 3,100 shares, a drop of 59.7% from the March 15th total of 7,700 shares. Based on an average daily trading volume, of 25,900 shares, the short-interest ratio is presently 0.1 days. View Bullfrog AI's Short Interest. How do I buy shares of Bullfrog AI? Shares of BFRGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BFRGW) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
